GlassScriptPhysician profile
Andrew Michael Rabin
NPI 1629154984
$706.61
in general payments reported to CMS, 2019-2025
12 companies · $40.32 in 2025
The $40.32 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2020: $43.43 · 2021: $16.18 · 2022: $257 · 2023: $142 · 2024: $63.39 · 2025: $40.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $245.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $245.15 | 2022 | |
| Ekos Corporation | $102.06 | 2019 | |
| Boston Scientific Corporation | $79.12 | 2020-2023 | |
| Terumo Medical Corporation | $55.95 | 2023 | Azur Cx Detachable, Angio-Seal, Glidesheath Slender |
| Inari Medical, INC. | $44.29 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Mozarc Medical US LLC | $40.32 | 2025 | Chameleon |
| Angiodynamics, INC. | $34.56 | 2022-2023 | Alphavac |
| Scientia Vascular | $27.88 | 2023 | |
| Cardinal Health 200 LLC | $26.30 | 2019 | |
| Cardiva Medical, INC. | $21.48 | 2024 | Cardiva Vascade 6/7f Vcs |
| Medtronic Vascular, INC. | $15.70 | 2019 | |
| Ge Healthcare | $13.80 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Rabin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.